Why the study?
Real-world data on factors associated with one-year mortality in hospitalized cardiac patients with hyponatremia are limited, and the temporal relationship between in-hospital predictors and long-term outcomes remains uncertain.
Cohort (n=119)
No
Answers are grounded in this paper and cite their sources.
In hospitalized cardiology patients with hypotonic hyponatremia, one-year mortality is high (44.5%), with severe chronic heart failure (stage II) and subclinical myocardial injury (elevated CK-MB) serving as more robust predictors of death than the severity of hyponatremia itself.
BACKGROUNDHyponatremia is a common electrolyte disorder in hospitalized cardiac patients and is associated with increased mortality.However, data on factors associated with one-year mortality in patients with hyponatremia in real-world clinical practice are limited, and the temporal relationship between in-hospital predictors and long-term outcomes remains uncertain. AIMTo explore factors associated with one-year mortality in cardiac inpatients with hyponatremia and assess the robustness of these associations in sensitivity analyses. METHODSThis retrospective single-center cohort study included 119 patients (mean age 71.2 ± 12.7 years, 48.7% female) hospitalized in a cardiology department with hypotonic hyponatremia.Patients with acute coronary syndrome and/or myocardial infarction were excluded.The primary endpoint was all-cause death within 1 year, ascertained through the regional electronic death registry.Cox regression was used.Sensitivity analyses excluding in-hospital deaths and Firth's penalized Cox regression were performed. RESULTSThe one-year mortality rate was 44.5% (53/119).In the primary multivariable Cox model, stage II chronic heart failure (CHF) [hazard ratio (HR) 8.86; 95% confidence interval (CI):1.81-43.39;P = 0.007], minimum sodium (HR 0.94; 95%CI: 0.89-1.00;P = 0.040), and peak creatine kinase-MB (CK-MB) (HR 1.02; 95%CI: 1.00-1.04;P = 0.002) were associated with one-year mortality.However, in a sensitivity analysis excluding in-hospital deaths, these associations were no longer statistically significant.In Firth's penalized model, CK-MB 4 / 35 (HR 1.02; 95%CI: 1.01-1.04;P = 0.007) and stage II CHF (HR 6.60; 95%CI: 1.67-33.37;P = 0.007) remained significant, whereas minimum sodium did not (P = 0.117).Non-linearity was not detected for sodium (P = 0.459) or CK-MB (P = 0.182). CONCLUSIONIn this exploratory analysis, CK-MB and stage II CHF were more robustly associated with one-year mortality than hyponatremia.The sodium association was not confirmed in sensitivity analyses.These findings are hypothesis-generating and require prospective validation.
No takes yet. Share an insight, caveat, or question.
Pereverzeva et al. (2026) conducted a cohort in Hypotonic hyponatremia in hospitalized cardiac patients (n=119). Stage II chronic heart failure, minimum plasma sodium, and peak CK-MB activity vs. No chronic heart failure / reference biomarker levels was evaluated on All-cause death within 1 year (HR 8.86, 95% CI 1.81-43.39, p=0.007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: